133 related articles for article (PubMed ID: 37178426)
41. Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics.
Balan D; Kampan NC; Plebanski M; Abd Aziz NH
Front Oncol; 2024; 14():1388663. PubMed ID: 38873253
[TBL] [Abstract][Full Text] [Related]
42. Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.
Meshcheryakova A; Svoboda M; Jaritz M; Mungenast F; Salzmann M; Pils D; Cacsire Castillo-Tong D; Hager G; Wolf A; Braicu EI; Sehouli J; Lambrechts S; Vergote I; Mahner S; Birner P; Zimmermann P; Brindley DN; Heinze G; Zeillinger R; Mechtcheriakova D
Comput Struct Biotechnol J; 2019; 17():537-560. PubMed ID: 31049165
[TBL] [Abstract][Full Text] [Related]
43. Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy.
Jiang A; Liu Y; Chen O; Liu Z; Cai H; Wang L; Qi L
Front Pharmacol; 2023; 14():1324212. PubMed ID: 38026999
[No Abstract] [Full Text] [Related]
44. Predictive medicine in a testis trio-family through a combined multi-omics approach.
Di Maggio F; Damaggio G; Nunziato M; Buonaiuto S; Crocetto F; Calabrese A; Aveta A; Vino G; Donvito G; Pandolfo SD; Imbimbo C; Colonna V; Salvatore F
Clin Transl Med; 2024 Apr; 14(4):e1643. PubMed ID: 38616705
[No Abstract] [Full Text] [Related]
45. Editorial: Multi-omics analysis of programmed cell death-mediated tumor microenvironment heterogeneity.
Jiang Y
Front Oncol; 2024; 14():1265418. PubMed ID: 38595819
[No Abstract] [Full Text] [Related]
46. Analysis of comprehensive biomolecules in critically ill patients via bioinformatics technologies.
Matsumoto H; Ogura H; Oda J
Acute Med Surg; 2024; 11(1):e944. PubMed ID: 38596160
[TBL] [Abstract][Full Text] [Related]
47. Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.
Salamini-Montemurri M; Lamas-Maceiras M; Lorenzo-Catoira L; Vizoso-Vázquez Á; Barreiro-Alonso A; Rodríguez-Belmonte E; Quindós-Varela M; Cerdán ME
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445988
[TBL] [Abstract][Full Text] [Related]
48. Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.
Alkema NG; Wisman GB; van der Zee AG; van Vugt MA; de Jong S
Drug Resist Updat; 2016 Jan; 24():55-69. PubMed ID: 26830315
[TBL] [Abstract][Full Text] [Related]
49. Immunotherapy and Cancer: The Multi-Omics Perspective.
Donisi C; Pretta A; Pusceddu V; Ziranu P; Lai E; Puzzoni M; Mariani S; Massa E; Madeddu C; Scartozzi M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542536
[TBL] [Abstract][Full Text] [Related]
50. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract][Full Text] [Related]
51. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract][Full Text] [Related]
52. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
53. Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An
Ruan X; Ye Y; Cheng W; Xu L; Huang M; Chen Y; Zhu J; Lu X; Yan F
Front Med (Lausanne); 2022; 9():894338. PubMed ID: 35721082
[TBL] [Abstract][Full Text] [Related]
54. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
Front Immunol; 2022; 13():983636. PubMed ID: 36159794
[TBL] [Abstract][Full Text] [Related]
55. MMDAE-HGSOC: A novel method for high-grade serous ovarian cancer molecular subtypes classification based on multi-modal deep autoencoder.
Wang HQ; Li HL; Han JL; Feng ZP; Deng HX; Han X
Comput Biol Chem; 2023 Aug; 105():107906. PubMed ID: 37336028
[TBL] [Abstract][Full Text] [Related]
56. Glycosaminoglycans in cancer therapy.
Wieboldt R; Läubli H
Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1187-C1200. PubMed ID: 35385322
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
